SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads
暂无分享，去创建一个
M. Rebelatto | S. Sridhar | K. Papadopoulos | M. Wick | Y. Tai | R. Herbst | N. Dimasi | A. Tiberghien | P. Howard | D. Tice | C. Kiefer | S. Gregson | Krista Kinneer | S. Phipps | John H. Meekin | Luke A Masterson | K. Anderson | A. Moriarty